The National Assembly finally adopted in second reading the modified article 46B, registering the right to oblivion for the cancer patients in health law. This new right shakes up the AERAS convention (Insuring and Borrowing with an Aggravated Health Risk) which involved too few patients.
This new right to be forgotten will allow adults to no longer declare their pathology 10 years after the end of treatment (compared to 15 years according to the AERAS convention) and young people diagnosed up to 18 years of age to no longer declare their cancer 5 years after their treatments (with AERAS only children had this right).
Finally, the law prohibits insurers from combining additional premiums and exclusions from cover in the same contract.
These texts have been enthusiastically welcomed by patient associations, in particular the Association Rose, which stresses in a press release that “These great advances crown three years of commitment by the Rose association and its community. In this fight which lasted three years, the Rose association was able to rely on its large community, active, involved, on the community oncologists whose biggest names have spoken alongside us to ask the public authorities not to be satisfied with an insufficiently protective Aeras convention”. The association regrets, however, that the right to be forgotten 5 years after the end of treatment for cancer patients with a good prognosis was not adopted, the deputies having retreated on this point compared to the vote of the senators “preferring to let the AERAS negotiators propose a cancer-by-cancer grid. We therefore challenge Mrs. Marisol Touraine on this point and would like more transparency in the negotiations concerning the establishment of this future grid.” emphasizes the Rose association.
Read also :
Unusual: a labrador detects the cancer of his mistress
Cancer: height would be a risk factor